Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists

Latest HealthInvest Partners AB Stock Portfolio

About HealthInvest Partners AB and 13F Hedge Fund Stock Holdings

On 2026-02-06, the fund reported it's updated stock portfolio. In the 13F Holdings report, Atle Fund Management AB reported an equity portfolio of $313.4 Millions as of 31 Dec, 2025.

The top stock holdings of Atle Fund Management AB are LLY, ABBV, MRK. The fund has invested 10.7% of it's portfolio in ELI LILLY & CO and 7.9% of portfolio in ABBVIE INC.

The fund managers got completely rid off EDWARDS LIFESCIENCES CORP (EW), MERUS N.V. (MRUS) and HARMONY BIOSCIENCE HOLDINGS (HRMY) stocks. They significantly reduced their stock positions in BICARA THERAPEUTICS INC, CORBUS PHARMACEUTICALS HOLDING (CRBP) and GILEAD SCIENCES INC (GILD). Atle Fund Management AB opened new stock positions in CVS HEALTH CORP (CVS), IONIS PHARMACEUTICALS INC (IONS) and INCYTE CORP (INCY). The fund showed a lot of confidence in some stocks as they added substantially to ARCELLX INC (ACLX), AMGEN INC (AMGN) and BEONE MEDICINES LTD-ADR (BGNE).

HealthInvest Partners AB Annual Return Estimates Vs S&P 500

  • Performance

New Buys

Ticker$ Bought
cvs health corp8,453,270
ionis pharmaceuticals inc7,307,940
incyte corp6,997,950
insmed inc4,851,020
abivax sa4,260,070
ideaya biosciences inc3,368,430
compass therapeutics inc3,137,860
pyxis oncology inc709,831
New stocks bought by HealthInvest Partners AB

Additions

Ticker% Inc.
arcellx inc62.12
amgen inc58.65
beone medicines ltd-adr33.29
vertex pharmaceuticals inc29.37
boston scientific corp25.38
irhythm technologies inc25.3
merck & co. inc21.66
stryker corporation17.86
Additions to existing portfolio by HealthInvest Partners AB

Reductions

Ticker% Reduced
bicara therapeutics inc-45.34
corbus pharmaceuticals holding-38.91
gilead sciences inc-35.02
cardinal health inc-22.53
dexcom inc-21.92
krystal biotech, inc-19.76
bridgebio pharma inc-19.13
cencora inc-16.9
HealthInvest Partners AB reduced stake in above stock

Sold off

Ticker$ Sold
mereo biopharma group plc-167,282
summit therapeutics inc-203,404
harmony bioscience holdings-269,397
edwards lifesciences corp-542,105
avidity biosciences inc-240,427
janux therapeutics inc-129,265
merus n.v.-479,766
HealthInvest Partners AB got rid off the above stocks

Sector Distribution

Sector%
Healthcare94.3
Others5.7

Market Cap. Distribution

Category%
MEGA-CAP35.6
LARGE-CAP33.7
MID-CAP18.6
UNALLOCATED6.1
SMALL-CAP4.8
MICRO-CAP1.2

Stocks belong to which Index?

Index%
S&P 50056.9
RUSSELL 200022.4
Others20.7
Top 5 Winners (%)%
BBIO
bridgebio pharma inc
1164.0 %
LLY
eli lilly & co
1126.1 %
KRYS
krystal biotech, inc
1095.4 %
AUTL
autolus therapeutics plc
1050.0 %
RVMD
revolution medicines inc
1044.8 %
Top 5 Winners ($)$
LLY
eli lilly & co
34.0 M
ABBV
abbvie inc
20.4 M
MRK
merck & co. inc
17.2 M
TMO
thermo fisher scientific corp
15.1 M
NBIX
neurocrine biosciences inc
12.5 M
Top 5 Losers (%)%
Top 5 Losers ($)$

HealthInvest Partners AB Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of HealthInvest Partners AB

Last Reported on: 06 Feb, 2026
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions